证券记录 · 已归档季度
RYTM
Rhythm Pharmaceuticals, Inc. · Healthcare · Biotechnology
12被追踪持有人
0Δ持有人
11.40M持有股份
$638.39M报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -1.3% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +6 | 44.38M | $4.90B | +14 | −7 |
| Q1 2026 | 109 | +6 | 41.83M | $3.64B | +11 | −6 |
| Q4 2025 | 102 | 0 | 43.14M | $4.62B | +3 | −2 |
| Q3 2025 | 20 | +1 | 28.88M | $2.92B | +2 | −2 |
| Q2 2025 | 17 | 0 | 22.96M | $1.45B | +1 | −1 |
| Q1 2025 | 14 | +2 | 11.52M | $610.22M | +2 | — |
| Q4 2024 | 12 | 0 | 11.40M | $638.39M | — | — |
| Q3 2024 | 11 | +3 | 9.71M | $508.75M | +3 | — |
| Q2 2024 | 8 | — | 9.56M | $392.54M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 6.57M | -8.9% | $367.86M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (被动) | 1.84M | — | $103.05M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 1.26M | 0.0% | $70.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 1.26M | 0.0% | $70.32M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Marshall Wace ✦ | 692.80K | +70.4% | $38.78M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Marshall Wace ✦ | 692.80K | +70.4% | $38.78M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 692.80K | +70.4% | $38.78M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 685.15K | +24.4% | $38.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 685.15K | +24.4% | $38.35M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (被动) | 205.65K | +210.3% | $11.51M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 48.20K | +1022.5% | $2.70M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 40.42K | -60.7% | $2.26M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Wellington Management ✦ | 25.55K | -7.8% | $1.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 25.55K | -7.8% | $1.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 25.55K | -7.8% | $1.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 25.55K | -7.8% | $1.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 15.86K | -51.7% | $887,675 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 15.86K | -51.7% | $887,675 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 15.86K | -51.7% | $887,675 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Millennium Management ✦ | 15.26K | -58.7% | $854,199 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 6.79K | -28.4% | $379,880 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 284 持有人, 72.02M 股份, $6.12B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 13
Garfield Alastair
Officer · 2.01K 股 · $233,031
Aug 13
Garfield Alastair
Officer · 1.56K 股 · $182,170
Aug 13
Garfield Alastair
Officer · 3.40K 股 · $402,167
Aug 13
Garfield Alastair
Officer · 800 股 · $95,335
Aug 13
Lee Jennifer Kayden
Officer · 75.83K 股 · $8.90M
Aug 12
Mazabraud Yann
Officer · 2.30K 股 · $257,138
Aug 12
Mazabraud Yann
Officer · 1.00K 股 · $112,856
Aug 12
Mazabraud Yann
Officer · 3.60K 股 · $413,477
Aug 12
Mazabraud Yann
Officer · 14.57K 股 · $1.68M
Aug 12
Mazabraud Yann
Officer · 18.21K 股 · $2.12M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据